Related Experiment Video
Updated: Feb 27, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1
Anne Slavotinek1, Heather Pua2, Ugur Hodoglugil3
1Division of Medical Genetics, Department of Pediatrics, UCSF, San Francisco, CA 94143-2711, USA.
Insights
A novel TBL1XR1 gene mutation, p.Tyr446Cys, is linked to Pierpont syndrome in a young male with severe developmental delays and distinctive features. This specific mutation causes a recognizable syndromic intellectual disability, unlike other TBL1XR1 variants.
Area of Science:
- Genetics
- Developmental Biology
- Medical Genetics
Background:
- Pierpont syndrome is a rare genetic disorder characterized by developmental delays, hypotonia, and distinctive facial and digital features.
- Mutations in the TBL1XR1 gene have been associated with intellectual disability and autism spectrum disorder.
Observation:
- A 7-year-old male presented with severe developmental delays, hypotonia, dysmorphic features, deep palmar/plantar creases, and soft tissue "pillowing" of hands and feet.
- Facial features included a high hairline, small eyes, bulbous nasal tip, large mouth, and small chin. He also had a submucous cleft palate, bilateral cryptorchidism, and hydronephrosis.
- Cranial imaging revealed an Arnold-Chiari malformation.
Findings:
- Exome sequencing identified a de novo heterozygous variant, p.Tyr446Cys, in the TBL1XR1 gene, previously reported in Pierpont syndrome.
- This mutation is located in the carboxy-terminal WD40 domain, potentially affecting interactions with co-repressor complexes and chromatin.
- The patient exhibited submucous cleft palate and hydronephrosis, features not previously reported with this specific TBL1XR1 mutation.
Implications:
- The p.Tyr446Cys variant in TBL1XR1 appears to cause a clinically recognizable syndromic form of intellectual disability, distinct from other TBL1XR1 mutations.
- This case expands the phenotypic spectrum associated with TBL1XR1 mutations, highlighting mutation-specific pathogenic mechanisms.
- Understanding these genotype-phenotype correlations is crucial for accurate diagnosis and potential therapeutic strategies for Pierpont syndrome and related disorders.
Abstract:
We present a 7-year old male with severe delays, hypotonia and dysmorphic features who had striking, deep palmar and plantar creases and pillowing of the soft tissues of the palms and soles. His facial features included a high anterior hairline, small eyes with narrowed palpebral fissures, a bulbous nasal tip with a short columella, and a large mouth with a thin upper vermilion, and small chin. He had a submucous cleft palate, bilateral cryptorchidism and hydronephrosis. Cranial imaging demonstrated an Arnold Chiari malformation that was also present in his maternal uncle by report. Exome sequencing revealed a de novo heterozygous sequence variant, p.Tyr446Cys, in TBL1XR1 that has previously been reported in six patients with Pierpont syndrome. This sequence variant occurs in the carboxy-terminal, WD40 domain of the protein. As TBL1XR1 is a critical component of the NCoR/SMRT co-repressor complex and the WD40 repeats are hypothesized to interact with histone H2B and H4, the mutation may impact protein interactions necessary for stabilizing the complex with chromatin. De novo missense and frameshift mutations and deletions involving TBL1XR1 have been described in patients with intellectual disability and autism, but without any of the dysmorphic findings or malformations associated with Pierpont syndrome, implying a mutation-specific mechanism for the pathogenicity of p.Tyr446Cys. Our case is the first individual with this mutation to have a submucous cleft palate and hydronephrosis, although his severe delays, hypotonia, dysmorphic findings and emerging scoliosis appear consistent with previous reports. His distinctive facial and digital features are further evidence that p.Tyr446Cys results in a clinically recognizable, syndromic form of intellectual disability in contrast to other TBL1XR1 mutations.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Pleiotropy
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
ATP Synthase: Structure
Epistasis

